We are live on ! Find out more
PAHC icon

Phibro Animal Health

138 hedge funds and large institutions have $264M invested in Phibro Animal Health in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

404% more call options, than puts

Call options by funds: $136K | Put options by funds: $27K

21% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 14

9% more capital invested

Capital invested by funds: $242M → $264M (+$22M)

1% more funds holding

Funds holding: 136138 (+2)

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

2.44% less ownership

Funds ownership: 102.69%100.25% (-2.4%)

Holders
138
Holders Change
+2
Holders Change %
+1.47%
% of All Funds
1.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
48
Reduced
47
Closed
14
Calls
$136K
Puts
$27K
Net Calls
+$109K
Net Calls Change
+$145K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$46.6M -$767K -63,951 -2%
BIP
2
Brandes Investment Partners
California
$30.7M +$2.95M +246,451 +12%
Pzena Investment Management
3
Pzena Investment Management
New York
$25.4M -$256K -21,391 -1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$17.7M -$5.16M -430,598 -24%
State Street
5
State Street
Massachusetts
$12.2M -$79K -6,592 -0.7%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$9.48M -$524K -43,715 -6%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$8.73M +$2M +166,776 +33%
Renaissance Technologies
8
Renaissance Technologies
New York
$6.81M -$571K -47,600 -8%
Hotchkis & Wiley Capital Management
9
Hotchkis & Wiley Capital Management
California
$6.65M -$319K -26,600 -5%
Morgan Stanley
10
Morgan Stanley
New York
$6.24M -$3.52M -293,390 -38%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$5.93M -$2.31K -193 -0%
N
12
Nuveen
North Carolina
$5.78M +$2.11M +176,168 +65%
DIA
13
Dana Investment Advisors
Wisconsin
$5.67M +$5.25M +438,380 New
Invesco
14
Invesco
Georgia
$4.42M +$327K +27,282 +9%
BGIM
15
Brandywine Global Investment Management
Pennsylvania
$3.72M
Charles Schwab
16
Charles Schwab
California
$3.27M +$98.8K +8,241 +3%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$3.2M +$45.6K +3,807 +2%
Northern Trust
18
Northern Trust
Illinois
$3.03M -$115K -9,579 -4%
Goldman Sachs
19
Goldman Sachs
New York
$2.88M +$325K +27,129 +14%
AQR Capital Management
20
AQR Capital Management
Connecticut
$2.31M +$2.14M +178,510 New
SEI Investments
21
SEI Investments
Pennsylvania
$2.27M -$72 -6 -0%
Wellington Management Group
22
Wellington Management Group
Massachusetts
$2.14M +$6.08K +507 +0.3%
American Century Companies
23
American Century Companies
Missouri
$2.04M +$1.16M +97,001 +159%
Wells Fargo
24
Wells Fargo
California
$1.92M +$426K +35,559 +31%
BCC
25
Bridge City Capital
Oregon
$1.78M +$53.1K +4,433 +3%

PAHC Hedge Fund Activity: Q1 2024 in Review

138 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2024, worth a combined $264M — up 9.1% from $242M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PAHC positions and 14 closed out — a net gain of 3 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Dana Investment Advisors, opening a new position worth an estimated $5.25M. The largest seller was Millennium Management, cutting an estimated $6.12M.

  • 138 institutional investors held Phibro Animal Health (PAHC) as of Q1 2024, up from 136 in Q4 2023.
  • Funds reported $264M of Phibro Animal Health stock for Q1 2024, up 9.1% quarter-over-quarter.
  • 17 funds opened new Phibro Animal Health positions in Q1 2024 and 14 closed out, a net change of +3 holders.
  • The largest Phibro Animal Health buyer in Q1 2024 was Dana Investment Advisors, an estimated $5.25M added.
  • The largest Phibro Animal Health seller in Q1 2024 was Millennium Management, an estimated $6.12M sold.

Based on aggregated 13F filings for Q1 2024.